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A plethora of 3D and microfluidics-based culture models have been demonstrated 
in the recent years with the ultimate aim to facilitate predictive in vitro models 
for pharmaceutical development. This article summarizes to date the progress 
in the microfluidics-based tissue culture models, including organ-on-a-chip and 
vasculature-on-a-chip. Specific focus is placed on addressing the question of what 
kinds of 3D culture and system complexities are deemed desirable by the biological 
and biomedical community. This question is addressed through analysis of a research 
survey to evaluate the potential use of microfluidic cell culture models among the 
end users. Our results showed a willingness to adopt 3D culture technology among 
biomedical researchers, although a significant gap still exists between the desired 
systems and existing 3D culture options. With these results, key challenges and future 
directions are highlighted.
This article summarizes the progress in the development of microfluidics-based 3D 
cell/tissue culture models to date, including organ-on-a-chip and vasculature-on-a-chip 
capable of mimicking in vivo tissue architecture. Specific focus is placed on addressing 
the question of what kinds of 3D culture and system complexities are deemed desirable 
by the biomedical community. A research survey targeting biomedical researchers 
was designed to evaluate the potential application of microfluidics-based 3D culture 
systems and a positive attitude was recorded among its participants.
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Human combat against lethal diseases such 
as cancer and age-related deterioration has 
long been hampered by a lack of effective, 
accessible and safe therapies. This can be 
partly attributed to the inefficiency of cur-
rent drug development practice [1], espe-
cially the low-predictive power of preclinical 
models [2–4]. Traditionally, drug screening 
starts in 2D petri dishes where immortal-
ized human cell lines are cultured in mono-
layers. Though easy for standardization, the 
petri dish system is too simplistic and lacks 
microenvironment complexity and physi-
ological relevance to living tissues. Too often, 
2D models produce false positive results, giv-
ing unreliable or even misleading predictions 
for down-stream tests [5]. Physiologically 
relevant conditions can be found in animal-
based systems such as ex vivo chicken chorio-
allantoic membrane assays, in vivo transgenic 
mice or mouse xenografts [6]. However, drugs 
that work well in an animal model often fail 
when translated in humans [7,8], due to the 
phylogenetically remote relationship between 
different species. In addition, animal stud-
ies have long been criticized for their high 
cost, labor-intensiveness, low reproducibility 
and poor controllability over physiological 
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parameters [9]. All these factors give rise to the emer-
gence of 3D culture technology, which aims to create 
a more controllable yet accurate culture platform for 
preclinical study. Figure 1 summarizes a number of 
established preclinical models with varying complexity 
for drug development. 
3D cell culture, as its name suggests, refers to the 
in vitro culture of human cell lines or patient-derived 
tissues in a more physiologically relevant, 3D minia-
ture niche [10]. Recent advances in this field include 
the design of extracellular matrix (ECM) mimick-
ing hydrogel matrices [11,12] and fiber scaffolds [13,14], 
microfluidic ‘organ-on-a-chip’ [15,16], self-assembled 
multicellular spheroids [17,18] and bioprinted micro tis-
sues [19,20]. Table 1 lists some of the key microenviron-
ment cues, and the reported methods to replicate them 
in 3D culture models. It is expected that by increas-
ing the structural, chemical and physical complexity 
of the in vitro culture environment, 3D cell culture 
will possess great advantages over the conventional 
2D culture and may demonstrate increased predictive 
power as a next-generation drug testing platform [21]. 
Moreover, since 3D culture niches accommodate 
human cells/tissues, they can potentially help bridge 
the gap between animal studies and human-based 
clinical trials [22]. With the drive toward drug screen-
ing, many of the aforementioned 3D culture designs 
have been commercialized into scalable multiwell 
plate format. Table 2 summarizes examples of some 
of the currently available 3D culture systems, rang-
ing from scaffold-based models such as 3D hydrogels 
and polymeric membranes to scaffold-free ones such 
as microfluidics, spheroids and direct-printed mini 
tissues.
With the rapid development of an extended range of 
enabling technologies for 3D cell culture, one question 
desperately needs to be answered: what determines an 
ideal 3D culture model? We believe at least three crite-
ria should be considered: balanced complexity and user-
friendliness, proven functionality and high control-
lability. First, an in vitro model needs to demonstrate 
considerable complexity in order to reproduce some 
of the key attributes of the natural cellular microenvi-
ronment. These elements, as summarized in Figure 2, 
include biomechanical stimuli, extrinsic forces, chemi-
cal gradients and cell–cell interactions. However, it is 
worth mentioning that the choice of the system and 
complexity always depends on the research question to 
be addressed. Second, in order to add value to basic 
science and clinical studies, a 3D culture model should 
demonstrate its physiological relevance, showcasing its 
capability to recapitulate key characteristics of in vivo 
scenarios and key functionalities of tissues/organs. 
Furthermore, a culture system has to be robust and 
highly controllable to facilitate standardization, 
high throughput and commercialization.
Figure 1. Preclinical and clinical models for drug development. With an increase in system complexity, preclinical 
models range from 2D petri dish, to 3D in vitro and ex vivo culture systems, to in vivo animal models. Clinical studies 
are based on human subjects and consist of four testing phases. 
CAM: Chicken chorioallantoic membrane assay.
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In this article, we will pay specific focus on address-
ing the question of what kinds of system complexities 
are deemed desirable by the biological and biomedi-
cal community. We first review the microfluidics-
based 3D culture technology for organ-on-chips and 
in vitro microvascular models. Then we present the 
results obtained from a questionnaire designed to 
evaluate the potential use of microfluidic cell culture 
among biomedical researchers. Key challenges and 
future direction for microfluidic 3D culture are also 
highlighted.
On-chip biomimicry
Microfluidics refers to the manipulation of fluids of 
small volume (usually less than 10 μl) inside a chan-
nel of sub-millimeter scale. At micro scale, various 
phenomena are prevalent in fluids: laminar flow, 
improved molecular diffusion and accelerated heat 
transfer. In the early 1990s when the first microflu-
idic chips were fabricated in glass or oxidized silicon, 
they were primarily used in microelectromechanical 
systems [84] and separation science [85]. Later, micro-
fluidics were introduced to the biomedical commu-
nity because of their potential to greatly reduce the 
consumption of expensive reagents and valuable sam-
ples. Another attractive attribute of microfluidics is 
that laminar flow enables the design of physiologically 
relevant fluidic patterns, chemical gradients and spa-
tially organized cells/ECMs. From the mid-1990s, the 
concept of on-chip biomimicry of tissues/organs using 
microfluidics-based miniature chips slowly began to 
prosper. Among the earliest attempts, Frame et al. 
designed branching micro tubes (20–50 μm in diam-
eter) etched on a borosilicate microscope slide glass 
to reproduce the geometry of the arteriolar microcir-
culation [86]. Endothelial cells were cultured inside 
the microchannel under perfusion of culture medium 
for up to 24 h. However, the microfluidic chips made 
of glass/silicon were brittle, the fabrication proce-
dure was slow and required a clean room facility. 
Therefore, scientists started to prototype microflu-
idic chips using a more robust and low-cost elastic 
polymer called polydimethylsiloxane (PDMS) [87]. 
This move from glass/silicon to PDMS drastically 
accelerated the application of microfluidics in biol-
ogy. PDMS chips are relatively easy to fabricate, and 
are able to generate statistically analyzable informa-
tion in parallel operation. Also of critical importance, 
the optical transparency of PDMS enables real-time 
imaging, which is desirable for almost all branches of 
biomedical research. Over the past decade, a myriad 
of microfluidic designs with complex microarchitec-
ture, significant bioelectrical and biochemical func-
tionality have been realized through the addition of 
pneumatic valves [88], pillars [89], droplets [90], elec-
trodes [91], hydrogel matrices [92] and electrospun fiber 
scaffolds [63,93]. Such delicate microfluidics platforms 
have the potential to be developed for 3D biomimetic 
tissues and organotypic cultures, for a range of bio-
medical purposes. One popular example is the micro-
Table 1. Functions of microenvironment cues and biomimetic examples in various 3D culture systems. 
Biomimetic 
microenvironment cues
Function 3D hydrogel Polymer 
scaffold
Microfluidics Spheroid 3D printing
Spatial organization of 
cells/ECMs
Reproduce 3D tissue structure [23,24] [25,26] [27,28] [29] [30,31]
Chemical gradient Reproduce gradient of signaling 
molecules/growth factors
[32,33] [34] [35,36] [37] – 
 
Coculture of heterotypic 
cells
Enable cell–cell cross-talk [38,39] [40,41] [42–44] [45,46] [47,48]
External force stimuli Enable biomechanical sensing [49,50] [51,52] [53,54] [55] [56,57]
ECM Reproduce structural, 
mechanical and chemical 
properties of ECM
[58,59] [60,61] [62,63] [64,65] [66,67]
Hypoxia Induce tumor angiogenesis [68] [69] [69–70] [64] [71]
Topography Direct cell motion and confine 
cell distribution
[72,73] [60,61] [74,75] [76] [77,78]
Simulated body fluids Reproduce blood/interstitial 
flow
– – [79–81] – –
Typical microenvironment features include spatial organization of cells/ECM, biochemical gradient, co-existence of heterotypic cells, external mechanical stimuli, 
ECM, hypoxia, topography and body fluids. Individual or a combination of microenvironment cues can be replicated using various 3D culture methods such as 
hydrogel matrix, fibrous polymer scaffold, microfluidics, multicellular spheroid and 3D printed tissue.
ECM: Extracellular matrix.
10.4155/fsoa-2016-0084 Future Sci. OA (2017) FSO173 future science group
Perspective    Liu, Gill, Shery Huang
Ta
b
le
 2
. C
h
ar
ac
te
ri
st
ic
s 
o
f 
co
m
m
er
ci
al
ly
 a
va
ila
b
le
 3
D
 c
u
lt
u
re
 s
ys
te
m
s.
3D
 c
u
lt
u
re
 
st
ra
te
g
y
C
o
m
m
er
ci
al
iz
ed
 
p
ro
d
u
ct
M
ai
n
 f
ea
tu
re
M
ax
im
u
m
 
cu
lt
u
re
 t
im
e
C
h
em
ic
al
 
g
ra
d
ie
n
t
Fl
o
w
C
o
cu
lt
u
re
EC
M
N
o
te
s
R
ef
.
Sc
af
fo
ld
-b
as
ed
 
cu
lt
u
re
 
B
io
m
im
es
ys
C
el
ls
 o
n
 t
o
p
 o
f 
h
ya
lu
ro
n
ic
 a
ci
d
 
sc
af
fo
ld
s;
 
9
6
-w
el
l f
o
rm
at
21
 d
ay
s
N
o
N
o
N
o
3D
 h
ya
lu
ro
n
ic
 
ac
id
-b
as
ed
 
h
yd
ro
g
el
H
ig
h
ly
 p
o
ro
u
s 
g
el
 (
15
0
–2
0
0 
μ
m
 
p
o
re
s)
; 
N
o
n
-u
n
if
o
rm
 
sp
h
er
o
id
s 
(5
0
–2
50
 μ
m
)
[9
6,
97
]
 
Li
ve
rC
h
ip
Po
ro
u
s 
m
em
b
ra
n
e 
se
p
ar
at
in
g
 t
w
o
 
co
m
p
ar
tm
en
ts
; 
12
-w
el
l f
o
rm
at
14
 d
ay
s
N
o
O
n
-c
h
ip
 
m
ic
ro
p
u
m
p
-
co
n
tr
o
lle
d
 
re
cy
cl
in
g
 
p
er
fu
si
o
n
H
et
er
o
ty
p
ic
 c
el
ls
 
o
n
 o
p
p
o
si
te
 
si
d
es
 o
f 
a 
m
em
b
ra
n
e
Po
ly
m
er
 
m
em
b
ra
n
e 
m
im
ic
ki
n
g
 
liv
er
 s
in
u
so
id
 
ar
ch
it
ec
tu
re
Li
m
it
ed
 t
o
 li
ve
r 
o
rg
an
[9
8,
99
]
M
ic
ro
fl
u
id
ic
 
ch
ip
s 
O
rg
an
o
Pl
at
es
 (
b
y 
M
IM
E
TA
S)
M
ic
ro
fl
u
id
ic
s;
 
3
8
4
-w
el
l 
fo
rm
at
15
 d
ay
s
C
o
n
tr
o
lla
b
le
 
g
ra
d
ie
n
t
Pe
rf
u
si
o
n
 
co
n
tr
o
lle
d
 b
y 
Ph
as
e 
g
u
id
e 
te
ch
n
o
lo
g
y
H
et
er
o
ty
p
ic
 
ce
lls
 in
 d
if
fe
re
n
t 
re
g
io
n
s 
o
f 
m
ic
ro
ch
an
n
el
s
3D
 h
yd
ro
g
el
 
in
se
rt
io
n
Fo
rm
at
io
n
 o
f 
m
ic
ro
va
sc
u
la
tu
re
 
(d
ia
m
et
er
 
<1
0
0 
μ
m
)
[1
00
,1
01
]
 
Sy
n
V
iv
o
In
d
iv
id
u
al
ly
 
p
ac
ke
d
 
m
ic
ro
fl
u
id
ic
 
ch
ip
s
10
 d
ay
s
C
o
n
tr
o
lla
b
le
 
g
ra
d
ie
n
t
E
xt
er
n
al
 
p
u
m
p
-
co
n
tr
o
lle
d
 
p
er
fu
si
o
n
H
et
er
o
ty
p
ic
 
ce
lls
/t
is
su
es
 
in
 d
if
fe
re
n
t 
re
g
io
n
s 
o
f 
m
ic
ro
ch
an
n
el
s
2D
 c
o
at
in
g
 o
f 
h
yd
ro
g
el
/E
C
M
 
m
o
le
cu
le
s
Li
n
ea
r/
b
if
u
rc
at
in
g
 
ch
an
n
el
s 
an
d
 
to
rt
u
o
u
s 
n
et
w
o
rk
s 
(d
ia
m
et
er
 
>1
0
0 
μ
m
)
[1
02
,1
03
]
Sc
af
fo
ld
-f
re
e 
ce
ll 
ag
g
re
g
at
es
 
In
Sp
h
er
o
Se
lf
-a
ss
em
b
le
d
 
m
u
lt
ic
el
lu
la
r 
sp
h
er
o
id
s;
 
9
6
-w
el
l f
o
rm
at
W
ee
k
s
G
ra
d
ie
n
t 
as
 
a 
fu
n
ct
io
n
 o
f 
d
ep
th
 w
it
h
in
 
sp
h
er
o
id
s
N
o
H
et
er
o
ty
p
ic
 c
el
ls
 
ag
g
re
g
at
ed
 in
 
sp
h
er
o
id
s
En
d
o
g
en
o
u
s 
EC
M
Ti
g
h
t 
ju
n
ct
io
n
; 
C
o
n
tr
o
lla
b
le
 
sp
h
er
o
id
 s
iz
e
; 
Li
m
it
ed
 b
y 
ce
lls
’ 
ab
ili
ty
 t
o
 f
o
rm
 
sp
h
er
o
id
s
[1
04
,1
05
]
 
E
xV
iv
e3
D
 (
b
y 
O
rg
an
o
vo
)
La
ye
r-
b
y-
la
ye
r 
b
io
p
ri
n
te
d
 
ti
ss
u
es
; 
av
ai
la
b
le
 in
 
m
u
lt
iw
el
l 
fo
rm
at
28
 d
ay
s
G
ra
d
ie
n
t 
as
 
a 
fu
n
ct
io
n
 o
f 
d
ep
th
 w
it
h
in
 
m
ic
ro
 t
is
su
es
N
o
C
o
n
tr
o
lla
b
le
 
sp
at
ia
l 
d
is
tr
ib
u
ti
o
n
 o
f 
h
et
er
o
ty
p
ic
 c
el
ls
En
d
o
g
en
o
u
s 
EC
M
Ti
g
h
t 
ju
n
ct
io
n
; 
C
o
n
tr
o
lla
b
le
 t
is
su
e 
si
ze
; 
W
id
e 
ch
o
ic
e 
o
f 
ce
ll 
ty
p
es
[1
06
,1
07
]
Tw
o 
ca
te
go
rie
s 
of
 3
D
 c
ul
tu
re
 s
ys
te
m
s 
ar
e 
co
m
m
er
ci
al
ly
 a
va
ila
bl
e.
 S
ca
ff
ol
d-
ba
se
d 
cu
ltu
re
 m
od
el
s 
us
e 
3D
 h
yd
ro
ge
l m
at
rix
es
 o
r 
po
ly
m
er
ic
 m
em
br
an
es
/s
ca
ff
ol
ds
 a
s 
m
in
ia
tu
re
 c
el
l c
ul
tu
re
 n
ic
he
s.
 S
ca
ff
ol
d-
fr
ee
 c
ul
tu
re
 
ca
n 
be
 r
ea
liz
ed
 b
y 
m
ic
ro
flu
id
ic
s,
 s
el
f-
as
se
m
bl
ed
 s
ph
er
oi
d 
or
 d
ire
ct
-p
rin
tin
g 
te
ch
no
lo
gi
es
. E
ac
h 
3D
 c
ul
tu
re
 m
et
ho
d 
is
 a
bl
e 
to
 r
ep
ro
du
ce
 a
 s
et
 o
f 
m
ic
ro
en
vi
ro
nm
en
t 
fe
at
ur
es
.
EC
M
: E
xt
ra
ce
llu
la
r 
m
at
rix
.
www.future-science.com 10.4155/fsoa-2016-0084future science group
Microfluidic on-chip biomimicry for 3D cell culture    Perspective
fluidic-based organ-on-a-chip systems [94,95], some of 
which are illustrated in Table 2.
Probably one of the most famous examples of micro-
fluidic organ-on-a-chip is the lung-on-a-chip realized 
by Huh et al. to mimic pulmonary edema [53]. Briefly, 
an upper air channel was separated from a lower liquid 
channel by a porous PDMS membrane, the opposite 
sides of which formed epithelium and endothelium 
layers respectively. Two side channels parallel to the 
central channels were connected to a vacuum pump 
that cyclically mimicked the breathing motion of the 
lung. This lung-on-a-chip is a hallmark achievement 
in organ-on-chip development and has inspired the 
development of other human organ chips such as the 
gut-on-a-chip [108], kidney on-a-chip [109] and placenta 
on-a-chip [62]. More complex microsystems have also 
been created for the ‘human-on-a-chip’, in which vari-
ous organ equivalents are integrated into one single 
chip. For example, a four-organ-chip was established 
by Maschmeyer et al., demonstrating long-term cocul-
ture of liver spheroids, an intestine barrier insert, a skin 
biopsy insert and a polymeric kidney membrane. The 
four biomimetic organs were interconnected through 
a microfluidic circulation system perfused with surro-
gate blood [110]. Such a multi-organ platform can be 
used to observe the systemic responses of intercom-
Figure 2. Key microenvironment homeostasis and spatiotemporal dynamics that are desirable to be modeled in 
in vitro 3D culture systems. All microenvironment cues are dynamic, heterotypic and drivers of cell behavior and fate. 
ECM: extracellular matrix; GF: growth factor 
Adapted from [82,83].
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municating organs during complex physiological and 
pathophysiological processes including food metabo-
lism and pharmacokinetics. Apart from culturing 
human organ-specific cell lines in microfluidic chips, 
other cell and tissue sources such as human tissue slides 
and pluripotent stem cells have also been reported. For 
instance, organotypic culture of brain slices for up to 
40 days were performed in a microfluidic system which 
enabled the compartmentalization of different func-
tional units of the brain as well as easy manipulation 
of selected neural circuits [111]. Stem cell culture using 
microfluidics was also demonstrated in a study on 
ECM-mediated neural stem cell differentiation [112]. 
Finally, it is worth mentioning that the microenvi-
ronmental cues for these biopsy-derived tissues or self-
organizing stem cells have to be well understood and 
carefully designed to ensure long-term culture as well 
as well-controlled cell fate [113].
Microfluidic vasculature models
Aside from microfluidic organ-on-a-chips, another key 
focus of tissue engineers is blood vessels and capillaries, 
which are the basic building blocks of almost all organs 
and many important tissue structures such as the blood–
brain barrier [114], lung alveoli [115] and renal glomeru-
lus [116]. Vasculature enables gas exchange in the body 
as well as the transport of nutrients, waste, pathogens, 
blood cells and circulating cancer cells. Lack of proper 
vascularization can induce the formation of necrotic 
cores [117], which has been a common problem in many 
large-scale tissue constructs. Of equal importance, 
vascular endothelial cells are active in many signaling 
events such as hypoxia-initiated angiogenesis [118], stem 
cell differentiation [119] and the insulin signaling path-
way [120]. Many cell–cell interactions that take place 
in vivo, including leukocyte–endothelium [121] and 
platelet–endothelium interaction [122], also involve the 
active participation of vascular endothelial cells. Vascu-
lature is indispensable in modeling any process that is 
circulation driven such as inflammatory responses [123], 
cardiovascular diseases [124], cancer intravasation [125] 
and extravasation [126]. Therefore, creating 3D in vivo-
like vasculature has always been an important research 
question in the engineering of tissue surrogates and 
disease-on-a-chip.
Thanks to the many advantages microfluidics pos-
sess, tissue engineers have been employing microfluid-
ics technology to mimic vasculature networks over the 
past two decades [127,128]. First, microfluidic channels, 
from a few to hundreds of microns in diameter, are 
a convenient tool to mimic the geometry of microcir-
culation. Second, flow in microfluidic devices can be 
tailored to recapitulate the dynamic and fluidic micro-
environment that cells experience in vivo including 
body fluids (blood and interstitial fluids), shear stress 
and mass transportation. One successful example is 
an endothelialized microvasculature developed by 
Tsai et al., with branching channels (smallest diameter 
of 30 μm) emulating a postcapillary venule. Using this 
hemodynamics-mimicking platform, they studied the 
effect of an inflammatory cytokine TNF-α and the 
drug hydroxyurea on microvascular obstruction under 
perfusion of patient blood [129]. Apart from the simu-
lation of vasculature anatomy and hemodynamics, 
spatiotemporally defined chemical gradients are also 
achievable in microfluidic devices by manipulating 
liquids of different chemical concentrations in parallel 
channels. Third, heterotypic cells can be subsequently 
seeded and cocultured in the same microfluidic chip. 
Such coculture capability offers significant conve-
nience for researchers interested in cell–cell interac-
tions [130] happening in tumor-immune response [131] 
and vasculogenesis [132]. To summarize, microfluidics 
provide unique microenvironmental attributes such 
as lumen architecture, flow and spatial distribution of 
cells/particles that are difficult to define using other 
3D culture technologies. Therefore, microfluidics rep-
resent a powerful tool in mimicking tissue structures 
requiring the presence of vascular networks.
Over the decade, various techniques have been 
established to pattern microfluidic networks for vascu-
lature generation. Table 3 summarizes the development 
of several microfluidic vasculature models. The most 
common and well established fabrication method is 
photolithographic moulding of PDMS. Microvessels 
of rectangular cross-section can be easily fabricated 
to be later populated by human vascular endothelial 
cells [133]. However, the diameter of these microvessels 
is limited by the resolution of soft lithography. Most 
microvessels patterned via soft lithography are able 
to mimic arteries and veins of more than 100 μm in 
diameter [42,89,134], but are far from reaching the geom-
etry of very fine capillaries (10–20 μm) [135]. In addi-
tion, most of the lithography-moulded microvessels are 
made of synthetic polymers including PDMS and are 
lined with a single layer of vascular endothelial cells. 
Such synthetic and monolayer structures are unable to 
mimic the natural architecture of blood vessel walls, 
which usually consist of stacked layers of endothelial 
cells, a basement membrane, pericytes, smooth muscle 
cells and fibroblasts. These stromal layers outside vas-
cular endothelium are known to be very important for 
endothelial junction performance [136,137]. To mimic 
the stroma surrounding blood vessels, alternative tech-
niques such as injection moulding have been devel-
oped to pattern vasculature inside ECM hydrogels. 
For instance, Baker et al. injection-moulded gelatin, 
a natural thermoplastic protein, into a microvascula-
www.future-science.com 10.4155/fsoa-2016-0084future science group
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ture construct and embedded it within collagen hydro-
gel [35]. The gelatin was then melted at 37°C and left 
open channels inside the collagen gel. The vasculature 
reached a diameter of less than 100 μm and the cross-
section was quasi-cylindrical. A similar strategy was 
developed in the same group, where 3D printed lat-
tices made of sacrificial carbohydrate glass were used 
to pattern vasculature inside ECM [138]. The glass lat-
tices were encapsulated within various ECM materi-
als along with living cells and later dissolved in cell 
media to create perfusable vascular networks. These 
microvessels had cylindrical lumen and a minimum 
diameter of around 200 μm. It is worth mention-
ing that compared with lithography-moulded planar 
microchannels, such cylindrical lumen closely mim-
ics the anatomy and hemodynamics of real blood ves-
sels [139]. Alternatively, viscous finger patterning [140], 
removable nitinol rods [141] and laser beams [142] were 
also used to pattern cylindrical microchannels inside 
ECM gels. For example, Hasan et al. inserted concen-
tric needles of varying diameters into a microchannel 
and subsequently loaded cell laden gelatin methacry-
loyl (GelMA) hydrogel into the annular interneedle 
space. The use of concentric needles was to create 
multilayered cylindrical vascular walls consisting of 
endothelial, smooth muscle and fibroblast layers [143]. 
A much easier approach to create ‘do-it-yourself ’ endo-
thelialized microfluidics was also reported in which 
researchers used removable polymethylmethacrylate 
optical fibers to pattern vasculature for the study of 
endothelial–blood cell interaction [144].
Using these aforementioned microfluidic fabrica-
tion methods, microchannel networks in the hundreds 
of micron scale can be patterned within synthetic or 
natural polymeric materials and be lined with vascular 
endothelial cells. This microvessel generation technique 
can be termed as ‘prevascularization technique’ [145]. 
However, to replicate the complex networks of fine 
capillaries, angiogenesis-assisted vascularization is a 
more appropriate strategy. Briefly, vascular endothelial 
cells are seeded inside ECM hydrogels with angiogenic 
stimuli such as shear stress and vascular endothe-
lial growth factor (VEGF) [130], and are cultured for 
days to form spontaneously interconnected capillary 
networks. The main limitation of the angiogenesis 
technique is that the system often requires a set of pre-
defined culture conditions, which restrict system tun-
ability and hemodynamic controllability. Table 4 cross-
compares the two vascularization approaches. It is of 
note that individual [43] or combined [146] strategies can 
be employed to address various research questions. To 
improve physiological relevance, important directions 
for the future development of biomimetic vasculature 
include: improving coculture complexity, refining 
vasculature dimension and enhancing fluidic control. 
Another issue is system validation. Although microflu-
idic microvasculature systems possess great potential 
for studies on hemodynamics and endothelial–blood 
Table 3. Characteristics of microfluidic vasculature generation technologies.
Microfluidic vasculature 
generation technology
Cross-section Geometry Note Advantages Ref.
Photolithographic 
moulding
Planar >30 μm Most developed 
and standardized 
technology
Fluid 
 Chemical gradient 
 Coculture
[42]
Injection moulding Quasi-
cylindrical
>20 μm Template molded in 
sacrificial material
Fluid 
Chemical gradient 
Coculture
[35]
Direct-write assembly Cylindrical 200–800 μm Template direct-
printed from 
sacrificial material
Fluid 
Chemical gradient 
Coculture
[138]
Viscous finger patterning Cylindrical 100–700 μm Less controllable 
vessel geometry
Fluid 
Chemical gradient 
Coculture
[140]
Removable rods Cylindrical 150 μm Stiff hydrogel to 
withstand rod 
removal
Fluid  
Chemical gradient 
Coculture
[141]
Laser micromachining Cylindrical 8 μm Precise control over 
small geometry
Fluid 
Chemical gradient 
Coculture
[142]
Microfluidic vasculature mimics the geometry of vascular networks and allows for simulated body fluids, gradient and cell coculture. Various 
techniques have been reported to pattern microfluidic networks for vasculature generation.
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cell interaction, very few of these devices have been 
directly validated against in vivo models. More cross-
system comparisons need to be completed to encour-
age wide applications of vasculature-on-chip.
Desirable culture features: a research survey 
analysis from the end user standpoint
Although a plethora of microfluidic-based culture 
models has been developed, as described above, the 
adaptation of these models to address biologically 
focused research questions is sparse. Among the 
biological community, which is the intended end 
user of 3D culture systems, a sceptical attitude still 
exists: potential customers are concerned about the 
reliability, functionality and reproducibility of engi-
neered tissues. To better appreciate the expectations 
and concerns of biomedical researchers, we designed 
a comprehensive survey to assess the acceptance of 
3D in vitro culture systems, focused on microfluidics. 
The questionnaire is shown as Supplementary Data 1. 
It includes 12 single choice questions investigating 
researchers’ background and acceptability of 3D cul-
ture models, five multiple choice questions on their 
preferences and suggestions, and one open question 
on the signaling pathways they are interested in. We 
invited via email 70 bioscience researchers from aca-
demia and the pharmaceutical industry, to participate 
in the survey. The participants were not filtered by 
their familiarity of the authors or by certain research 
fields. Among the invited participants, 46 were world-
renowned bioscientists who have published highly 
cited articles (from 2006 to date) in 15 top biosci-
ence journals such as Nature Biotechnology, Journal of 
Cell Biology, Cell and Nature Reviews Molecular Cell 
Biology. Another 24 lab-based biomedical research-
ers including PhD students and early-career Postdocs 
(mainly based in the University of Cambridge) were 
also involved in the survey.
In total, 42 researchers completed the question-
naire which translates to a response rate of 60%. The 
participants contain a combination of 15 research 
group leaders, 24 lab-based researchers and three 
industrial scientists (see Figure 3A). Their research 
covers areas including cancer, neuroscience, stem 
cell, toxicology, endocrinology and aging. Signaling 
molecules and pathways such as p53, Rho GTPases, 
integrin, EGFRs, ROS, WNT, IR, HIF-1 are indi-
cated as a subject of interest. Further, major analyti-
cal tools used by these researchers were investigated 
to identify which type of downstream assays a cul-
ture system should be able to adapt to. The data 
revealed that typical analytical methods employed 
by biomedical researchers include western blot-
ting, polymerase chain reaction (PCR), immune-
fluorescent microscopy, live cell imaging and flow 
cytometry (Figure 3D). When it comes to the usage 
of 3D culture systems such as microfluidic chips, 
the majority of the researchers did not have previous 
experience. One out of five used microfluidics occa-
sionally and only 7.1% were familiar with this tech-
nique (Figure 3B). However, 85.7% (36 out of 42) 
of the researchers expressed a clear interest in adopt-
ing microfluidic culture in their research, either 
performed by themselves (50%) or by collaborators 
(35.7%) such as a provider company or a collabora-
tive research group (Figure 3C). When queried about 
key obstacles that may prevent the uptake of new cell 
culture technologies, researchers listed five major 
concerns as system reproducibility, standardization, 
validation, ease of use and compatibility with ana-
lytical assays (Figure 3E), which should be overcome 
by future 3D models. However, we would like the 
reader to note that due to the relatively small size of 
the cohort, there is a possibility that this study may 
not capture all the opinions of researchers from the 
different fields.
Table 4. Principle, advantages and disadvantages of two vasculature generation strategies.
Vasculature generation 
strategy
Principle Advantages Disadvantages
Prevascularization Endothelial lining of 
predefined vasculature
Precise control over 
vasculature architecture 
Precise control over flow
Simple geometry 
Low resolution
Angiogenesis-assisted 
vascularization
Chemical-induced 
angiogenesis in 
endothelial-embedded 
hydrogel
Complex geometry, 
dense network 
Cylindrical lumen 
Self-organized capillaries
Limited to tumor 
vasculogenesis 
Low controllability over 
flow 
Slow formation of 
vasculature
Prevascularization refers to the lining of vascular endothelial cells in the lumen of patterned microvasculature, suitable for mimicking veins 
and arteries of more than 50 μm in diameter. Angiogenesis-based vascularization refers to spontaneous capillary (diameter <20 μm) 
formation inside extracellular matrix hydrogels.
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As aforementioned, an ideal 3D culture model 
should demonstrate considerable microenvironment 
complexity to achieve a close resemblance to natural 
tissues. Therefore, details of desirable microenviron-
ment features determined by biomedical researchers 
were summarized in Supplementary Figure 1. We classi-
fied two subgroups in the cohort: the ‘advanced-career 
researchers (ACR)’ group (18 out of 42), referring to 
scientists who have more than 7 years of research expe-
rience in their fields; and the ‘early-career researchers 
(ECR)’ (24 out of 42), referring to researchers with 
less than 7 years of experience. This classification is 
for the purpose of generating a detailed observation 
on the preference of scholars within these two groups. 
In total, eight microenvironment factors were evalu-
ated and the importance of each factor was weighed 
using a scoring scale of 0–4 (Supplementary Figure 1A), 
where 0 was classified as ‘not important at all’, and 4 
as ‘absolutely essential’. The data suggested that both 
subgroups agree on the importance of the spatial orga-
nization of cells/ECM in a 3D culture system; whereas 
varying views were recorded for the remaining seven 
features. For instance, 88.88% of the ‘ACR’ group 
scored above 3 (‘very important’ to ‘absolutely essen-
tial’) for the ‘coculture’ factor, while only 50% of the 
‘ECR’ group expressed such a strong preference. This 
difference reflected a variance in researchers’ actual 
need and expectation for new culture models, which 
Figure 3. Characterization of research area, usage and acceptability of microfluidic culture systems, usage of analytical tools and 
concerns about new culture technology among biomedical researchers. (A) The cohort consists of scientists from fundamental, 
interdisciplinary research and drug discovery industry. (B) Few researchers have previous experience of using complex 3D culture 
models including microfluidics. (C) Acceptance of 3D culture systems including microfluidics is a predominant response. (D) Popular 
analytical tools for biomedical scientists include western blotting, PCR, immunofluorescence microscopy, live cell imaging, flow 
cytometry and ELISA. (E) Potential users are concerned about the reproducibility, standardization, validation, user-friendliness and 
compatibility of new culture technology. 
PCR: Polymerase chain reaction. 
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may influence their final decision making as well as 
the design priority and marketing strategy of 3D cul-
ture developers. The average weight of each microenvi-
ronment factor was listed in Supplementary Figure 1B, 
with spatial organization, coculture and ECM ranked 
as essential characteristics (scored around or above 
3), while external force stimuli, topography, fluids, 
hypoxia and chemical gradient as desirable features 
(scored between 2 and 3).
Further details of researchers’ preference on other 
3D culture characteristics were shown in Figure 4. The 
two subgroups have varying views on the choice of 
coculture number, ECM, product type and price. For 
instance, half of the ‘ACR’ group desired a complex 
system that is able to coculture at least four types of 
cells, while a greater percentage (60%) of the ‘ECR’ 
expected a simpler system enabling only two types 
of cells in coculture (Figure 4A). As for the preferred 
method to incorporate ECM, a majority of the ‘ACR’ 
group opted for 3D fibrous scaffolds, hydrogel matri-
ces and endogenous ECM, while half of the ‘ECR’ 
favored a simpler, 2D thin coating of ECM compo-
nents (Figure 4B). Similarly, the ‘ACR’ preferred more 
customized, complex systems and were willing to pay 
up to three-times higher prices. By contrast, the other 
group showed greater interest in standardized models 
and expected lower prices (Figure 4C & D). In sum-
mary, ‘ACR’ have higher expectations for the complex-
ity, physiological relevance of a 3D culture system and 
expressed clear interest in customizable products. This 
variance in researchers’ decision making, even some-
times subtle, should be considered in the design and 
marketing of 3D culture systems.
With researchers’ high expectation for 3D culture 
in mind, it is worth mentioning that the time and 
effort needed for system installation often increases 
with system complexity, as does the end user input and 
system variability. Therefore, it is important to assess 
researchers’ requirement on the installation, usage and 
performance of 3D culture systems. Our data revealed 
that 61.9% (26 out of 42) of the researchers would like 
to see the completion of the preliminary training and 
setting up of a 3D culture platform within 4 weeks 
(Supplementary Figure 2A). Approximately half of the 
cohort expected similar or higher success rate in the 
new systems, in comparison to the traditional 2D sys-
tems. However, this expectation is currently difficult 
to achieve because 3D culture has not yet entered its 
maturity stage. For instance, many of the complex 
3D culture models often fail to reach expected lev-
els of robustness and reproducibility. With this in 
mind, 28.6% of the cohort accepted a 20% decrease 
in success rate and 21.4% accepted a 50% decrease 
(Supplementary Figure 2B). As to the preparation time, 
more than one-third of the researchers expected to 
have a 3D culture device made within 3 days, while 
a greater percentage (45.2%, 19 out of 42) are willing 
to wait for 4–7 days (Supplementary Figure 2C). Also, 
it can be concluded that depending on the research 
purpose, the required time that cells be maintained 
in a 3D culture device varies from days to weeks 
(Supplementary Figure 2D).
Overall, willingness to adopt 3D culture was the 
prominent response among biomedical researchers. 
Key microenvironment features desired by research-
ers are spatial organization, ECM and coculture of 
heterotypic cells. Other desirable factors, depending 
on the research question to address, include exter-
nal force stimuli, topography, simulated body fluids, 
hypoxia and chemical gradients. These results reso-
nate with experts’ opinions expressed in other reviews 
on 3D culture [147–150]. In addition, we observed slight 
variance in the decision making of end users in that 
‘ACR’ opted for 3D models with higher coculture 
ability, closer physiological relevance and were willing 
to pay higher prices for customized models. Despite 
this positive attitude, our survey implied that there 
still exists a significant gap between the model com-
plexity demanded by especially the ACR, and the 
capability demonstrated in existing culture systems 
(as summarized in the previous sections). Although 
current microfluidic chips, including some commer-
cialized ones such as OrganoPlates, offer a convenient 
system that to some extent mimics in vivo conditions, 
few studies using these culture models have been pub-
lished in leading journals in fundamental biomedical 
research or pharmaceutical science. Most engineered 
culture systems are able to demonstrate spatial orga-
nization in their biomimetic architectures but lack 
comprehensive downstream physiological or pharma-
cological analysis that can fully validate their func-
tionality. Some exceptions do exist, as illustrated in 
the recent work by Soroush et al., in which a microflu-
idic vascular network based on in vivo images revealed 
a key role of protein kinase C δ in neutrophil tran-
sendothelial migration [79]. However, a more ‘killer 
application’ may need to be showcased to stimulate 
a broader uptake of 3D culture models. We believe 
that achieving a critical set of ‘baseline’ complexity 
desired by the biomedical researchers, simultaneously 
with improved system reproducibility, functionality 
and user friendliness are the critical stepping stones 
toward the broader adoption of 3D culture technolo-
gies. Otherwise, there is not a strong enough incentive 
for the biological community to modify their culture 
protocols and invest in a new, nonstandardized plat-
form. This hesitation may be a hurdle for new culture 
systems to be accepted as valuable tools for funda-
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mental biomedical research and drug screening in an 
industrial context.
Conclusion
The versatile functionality and excellent spatiotemporal 
control over microenvironmental elements in 3D cell 
culture opens up wide possibilities for tissue engineering 
and next generation drug testing. Specifically, the ability 
of microfluidics to biomimic the fluidic in vivo micro-
environment and micron-scale luminal structures can 
be a powerful tool in the creation of organ/vasculature-
on-chips. According to our research questionnaire, will-
ingness to adopt 3D culture technology was a promi-
nent response among biomedical researchers, although 
a significant gap still exists between the desired systems 
and existing 3D culture options. The survey may pro-
vide academic insight for entrepreneurs who are inter-
ested in the commercialization of microfluidic-based 
3D culture systems.
Future perspective
The past two decades have seen the emergence and 
rapid growth of microfluidics-based 3D culture tech-
nology, with the ultimate aim to boost the develop-
ment of fundamental bioscience and pharmaceutics. 
A plethora of interesting microfluidic models have 
been engineered, such as the biomimetic organ- and 
vasculature-on-a-chip. Despite the many advantages 
microfluidics offer, they are not without weaknesses. 
The miniaturization empowered by microfluidics also 
implies that accessible cells/tissues in the culture sys-
tem can be too few to be further studied using conven-
tional analytical tools, such as western blotting, ELISA 
and mass spectrometry. Although some on-chip assays 
including single-cell PCR [151] and western blotting [152] 
have been developed for the small sample input from 
microfluidics, samples in current biomimetic chips 
are mostly studied using 2D/3D imaging techniques 
including epifluorescence and confocal microscopy. 
Figure 4. Coculture number, extracellular matrix, product type and price expected by researchers. (A) ACR prefer complex 3D culture 
systems enabling the coculture of more than four types of cells. ECR require two or three cell types in coculture. (B) ACR prefer 3D 
scaffold/hydrogel and endogenous ECM. ECR prefer thin coating of ECM molecules and 3D scaffold/hydrogel. (C) ACR prefer more 
customized culture systems. ECR require standardized products. (D) ACR are willing to pay double or even triple price for 3D culture 
models. ECR will pay less. 
ACR: Advanced-career researcher; ECM: Extracellular matrix; ECR: Early-career researcher. 
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However, the wide adaptation of microfluidics-based 
culture methods requires that the systems be validated 
from a multidimensional angle, by various analyti-
cal tools. Therefore, either the culture models should 
be designed more compatible with existing analytical 
methods, or more sensitive, advanced analytical/imag-
ing tools have to be developed for or even integrated in 
microfluidic chips [153]. In addition, most microfluidic 
systems, compared with the conventional petri dishes, 
are far less user friendly. Although standardized proto-
cols are now available [42,154], microfluidic systems are 
still labor-intensive to fabricate and complex to oper-
ate. For example, microfluidics often require specific 
training on the pipetting/coating techniques as well as 
complicated external setups such as syringe pumps. It 
is therefore desirable but still challenging that future 
microfluidics incorporate intelligent on-chip control 
of oxygen/medium perfusion, while user operation is 
simplified at the same time.
Though creating a fully functional artificial organ 
may seem too ambitious, tissue engineers could work 
toward achieving a decent level of complexity, both 
structurally and functionally, and from micro to nano 
scale, in one biomimetic culture system. To realize 
more physiologically relevant tissue architecture and 
microenvironment dynamics, microfluidics should 
explore new fabrication materials beyond PDMS [155], 
and be combined with other bioengineering tools such 
as nano-fibrous scaffolds, biosensors and 3D print-
ing [156]. However, for tissue engineering scientists, 
developing cutting-edge technology for 3D culture is 
no longer the only focus. The bioengineering commu-
nity should reach out proactively to their biomedical 
end users, to seek their mutual interests, finding design 
inspiration from their feedback.
Encouragingly, our research survey revealed that 
a positive attitude toward 3D culture prevails among 
biomedical scientists and pharmaceutical researchers. 
In fact, the past decade saw many encouraging attempts 
to apply 3D culture in areas such as cancer metastasis 
research [157–159] and early-phase drug screening [160]. 
For instance, a microfluidic device with interconnected 
chambers housing liver, tumor and marrow cells was 
used to test the metabolism-dependent cytotoxicity of 
an anticancer drug, Tegafur [161]. Other applications of 
microfluidic culture can be found in neuroscience, for 
purposes of complementing in vivo studies on neuro-
nal signaling [162] and high throughput evaluation of 
neurotoxic compounds [100]. These examples showed 
how microfluidics-based culture systems can help to 
bridge the gap between in vitro and in vivo study. As 
such, we believe that a lot more exciting research with 
impactful clinical effect can be performed when 3D 
culture systems are employed in broader areas. For 
instance, microfluidics-based 3D culture can be fur-
ther applied for the culture of patient-derived biopsy, 
for the purpose of developing personalized therapy. 
Microfluidics also represents a desirable tool to help 
test our understanding on human stem cell niches, 
organ development and regenerative medicine. How-
ever, in order to become a widely accepted tool in fun-
damental bioscience and pharmaceutical industry, 3D 
culture models have to find suitable research questions 
to address and impart tailored complexity, while over-
coming drawbacks such as poor compatibility, rela-
tively low throughput, limited functionality and lack 
of a standardized metric in cross-system comparison.
Supplementary data
To view  the  supplementary data  that accompany  this paper 
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Executive summary
•	 An ideal 3D culture system should demonstrate a balance of complexity, user-friendliness, physiological 
relevance and controllability.
•	 Microfluidics is a valuable tool for the development of organ- and vasculature-on-a-chip.
•	 Willingness to adopt 3D culture technology was a prominent response among biomedical researchers, 
although a significant gap still exists between the desired systems and existing 3D culture options.
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